about
The Presence, Persistence and Functional Properties of Plasmodium vivax Duffy Binding Protein II Antibodies Are Influenced by HLA Class II Allelic VariantsVariation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax RelapsesmCSM-lig: quantifying the effects of mutations on protein-small molecule affinity in genetic disease and emergence of drug resistancePlatinum: a database of experimentally measured effects of mutations on structurally defined protein-ligand complexes.In silico functional dissection of saturation mutagenesis: Interpreting the relationship between phenotypes and changes in protein stability, interactions and activity.mCSM-NA: predicting the effects of mutations on protein-nucleic acids interactions.GASS-WEB: a web server for identifying enzyme active sites based on genetic algorithms.SDHA related tumorigenesis: a new case series and literature review for variant interpretation and pathogenicity.pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures.CSM-lig: a web server for assessing and comparing protein-small molecule affinities.Analysis of HGD Gene Mutations in Patients with Alkaptonuria from the United Kingdom: Identification of Novel MutationsTwelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on 'black bone disease' in Italy.Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma.Functional interactions between polypyrimidine tract binding protein and PRI peptide ligand containing proteins.Combating mutations in genetic disease and drug resistance: understanding molecular mechanisms to guide drug design.PDBest: a user-friendly platform for manipulating and enhancing protein structures.mCSM-AB: a web server for predicting antibody-antigen affinity changes upon mutation with graph-based signaturesmCSM: predicting the effects of mutations in proteins using graph-based signatures.An integrated computational approach can classify VHL missense mutations according to risk of clear cell renal carcinoma.DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach.aCSM: noise-free graph-based signatures to large-scale receptor-based ligand prediction.HydroPaCe: understanding and predicting cross-inhibition in serine proteases through hydrophobic patch centroids.Familial STAG2 germline mutation defines a new human cohesinopathy.A Computational Approach From Gene to Structure Analysis of the Human ABCA4 Transporter Involved in Genetic Retinal Diseases.Protein cutoff scanning: A comparative analysis of cutoff dependent and cutoff free methods for prospecting contacts in proteins.Kinact: a computational approach for predicting activating missense mutations in protein kinases.DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability.mCSM-AB2: guiding rational antibody design using graph-based signaturesmCSM-PPI2: predicting the effects of mutations on protein-protein interactionsHuman LC3 and GABARAP subfamily members achieve functional specificity via specific structural modulationsVariant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma
P50
Q28396379-39E53AE4-EB12-41BD-855A-A11024AB5B14Q28553162-53376757-E2F7-4DB1-BA3F-0806B4F3FFCFQ28831145-AF0E5C63-2261-4018-9DFE-C7E9F0D52546Q30367904-815F35D3-D2D4-4708-A00C-4A11752517C1Q30383747-C5F165A5-4045-4DC9-B088-38F863D2562DQ30400796-1E93B212-CF19-4D73-B868-A982F6C02DA1Q30401543-57017370-30ED-426C-A0E7-A9C956776CF1Q33718501-C6FFEBCC-2D36-46D2-9382-15D915B9AFE8Q35599192-3CBAF9D1-99B4-43D0-B0E4-B76CF02DDCD9Q36010254-DC959D31-0328-40F3-B7A8-BB2D9DE370E8Q36090530-3D8B67D1-7F74-4016-9444-537FB16C5F64Q36695799-69A380D7-B7ED-46F3-A9AD-8B544EDE2F34Q38887353-EB90E003-87A9-4BD1-B3C0-83F39A4F7C49Q38928601-9B766C79-F024-490B-9899-9BB3DCA71E36Q39296374-461A5274-3D60-4FDD-BC42-6CF8A87D7F1CQ41016834-F00CCFE0-5330-4623-8FC2-C320E545F118Q41723015-2B13324A-B14F-437D-B524-C36ED184C355Q41877619-9A79C5EF-70AC-42BF-A334-063DE0AE44D0Q41882621-052F2838-7579-48C6-B4FB-4697C117FCE4Q41886851-1E59CE85-6AE2-4129-B8D0-22269BF9C940Q44831700-0DC0FA54-FA56-44D8-BECD-E701E6FB659FQ45996320-CA73ED40-2283-415E-AEB5-1BF3DCB34198Q47165215-B6775D5E-0175-48AD-BC59-AB3EDB612C11Q47628653-77DD4BF2-FA8A-4871-9CBD-4949A2F6480FQ53042799-FEE15E51-8FF1-4FC3-8DA5-52FEF2E30970Q54978537-70E612DB-5B96-42D6-984B-5790D99B94EDQ55479193-D52700D8-671A-4AE1-BEA4-7A751329B2CEQ91006031-E49FD2BF-F0B6-481A-AE49-53799320742EQ92202942-F79E109E-44F8-4AFB-BCE1-3A6F9A043B95Q93079343-7FB013B7-6639-4E98-8490-76EB7DCC152EQ93161726-C8BE3147-347E-44F1-92F4-97FA6895A64A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Douglas E V Pires
@en
Douglas E V Pires
@nl
type
label
Douglas E V Pires
@en
Douglas E V Pires
@nl
prefLabel
Douglas E V Pires
@en
Douglas E V Pires
@nl
P2456
P31
P496
0000-0002-3004-2119